Infusions frequently cause tiredness, and the reasons vary depending on what is being infused, what medications you receive before the drip starts, and how your immune system reacts to the substance entering your bloodstream. For some people the fatigue is mild and clears within hours; for others it follows a predictable cycle that returns with every treatment session. The causes range from straightforward drug side effects to subtler shifts in immune signaling, blood chemistry, and even the stress of sitting in an infusion chair for hours at a time.
The Pre-Medication You Get Before the Infusion
One of the most common and most overlooked causes of post-infusion tiredness is not the infusion itself but the medications given beforehand to prevent allergic reactions. Many infusion protocols call for an antihistamine before the main drug is administered, and the go-to choice for decades has been diphenhydramine, the same sedating antihistamine sold over the counter as a sleep aid. When given intravenously, diphenhydramine hits faster and harder than an oral dose, and it reliably makes people drowsy.
A phase 2 study comparing intravenous cetirizine to intravenous diphenhydramine as pre-medication found that patients who received diphenhydramine reported substantially higher sedation scores at every measured time point. At the one-hour mark, the diphenhydramine group’s average sedation rating was more than double the cetirizine group’s score, and the gap persisted through discharge.1PubMed Central. Intravenous Cetirizine vs Intravenous Diphenhydramine for the Prevention of Hypersensitivity Infusion Reactions: Results of an Exploratory Phase 2 Study If you consistently feel wiped out after infusions that include diphenhydramine as a pre-med, that single drug may be the main culprit. Asking your infusion team whether a non-sedating alternative is available is one of the simplest changes you can make.
How Your Immune System Reacts to What Is Being Infused
Beyond pre-medications, the infused substance itself can trigger your immune system in ways that produce fatigue. This is especially relevant for biologic drugs, which are large, complex molecules derived from living cells. When a biologic enters your bloodstream, immune cells sometimes recognize it as foreign and release signaling molecules called cytokines. That cytokine burst produces what feels a lot like the opening act of the flu: low-grade fever, chills, muscle aches, and fatigue. These symptoms are typically worst with the first infusion and tend to fade with subsequent doses as your body adjusts.2PubMed. Mechanisms of adverse drug reactions to biologics
A similar pattern shows up in chemotherapy. Research on patients receiving paclitaxel found that certain inflammatory cytokines spiked after treatment, and the timing matched when patients reported the worst fatigue and flu-like symptoms, generally around day three after infusion.3PubMed. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy A separate study of breast cancer patients on anthracycline chemotherapy found that rises in specific inflammatory markers were directly associated with increased fatigue and poorer quality of life during treatment.4PubMed. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer In both cases, your body’s inflammatory response to the drug, not just the drug’s direct toxicity, is a major driver of the tiredness you feel.
This cytokine-driven fatigue is not limited to chemotherapy. A Dutch registry study of over 1,300 patients receiving various biologic therapies found that about 8% reported fatigue as a recurring side effect, and nearly half of those described episodes that appeared during or shortly after injection and returned predictably with each dose. The encouraging part: almost all of those patients recovered or improved within a week of administration.5PubMed Central. Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor
The IVIG Wear-Off Cycle
Patients who receive intravenous immunoglobulin (IVIG) describe a distinctive fatigue pattern that does not quite match the “infusion day tiredness” most people expect. IVIG is used to treat immune deficiencies and autoimmune conditions, and it is typically given in cycles every few weeks. The side effects during or immediately after an infusion tend to be mild and transient: flushing, headache, chills, and fatigue that clears within a day or two.6PubMed Central. Adverse Effects of Immunoglobulin Therapy
But many IVIG patients report a second wave of fatigue that arrives later in the cycle, as the infused immunoglobulins are gradually used up and levels begin to drop. A study tracking quality-of-life measures throughout the IVIG cycle found that patients felt measurably better about seven days after their infusion, with lower fatigue scores and improved well-being, compared to the day of the infusion itself. These improvements then faded as the next infusion date approached.7PLOS ONE. Fluctuations in quality of life and immune responses during intravenous immunoglobulin infusion cycles This “wear-off” effect means that for IVIG patients, the worst fatigue may not be on infusion day but in the days just before the next one.
A large survey of patients with common variable immunodeficiency underscored how widespread this problem is. Roughly three-quarters of respondents reported fatigue, but patients on IVIG reported significantly higher rates than those receiving subcutaneous immunoglobulin injections at home. Among IVIG recipients, fatigued patients also reported more infections and used more antibiotics during the wear-off window, suggesting that the fatigue tracks with declining immune protection rather than being a simple drug side effect.8Clinical and Experimental Immunology. Fatigue and the wear-off effect in adult patients with common variable immunodeficiency This makes IVIG fatigue particularly tricky to manage, because some of it is caused by the infusion process and some is caused by the underlying disease resurfacing between doses.
Iron Infusions and Phosphate Drops
Iron infusions are commonly prescribed for severe anemia, and patients often expect them to boost energy. They usually do, but sometimes the days immediately following an iron infusion feel worse before they feel better. Part of this is the body’s inflammatory response to a large bolus of intravenous iron. Part of it, in some patients, involves a less obvious mechanism: a drop in blood phosphate levels.
Certain intravenous iron formulations can cause the body to waste phosphate through the kidneys, leading to a condition called hypophosphatemia. Phosphate is essential for cellular energy production, so when levels drop significantly, fatigue, muscle weakness, and bone pain can follow. Case reports have documented severe, prolonged hypophosphatemia after iron infusions, with symptoms persisting for weeks in some patients.9PubMed Central. Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction This side effect is considered underrecognized, partly because the fatigue it causes can easily be mistaken for the anemia that prompted the infusion in the first place. If your energy does not improve or actually worsens after an iron infusion, asking your doctor to check phosphate levels is reasonable.
What Else Is in the Bag
The active drug is not the only thing entering your vein during an infusion. Medications are formulated with inactive ingredients, stabilizers, and surfactants that can produce their own side effects. Polysorbate 80, a common emulsifier used in many injectable drugs, has been linked to hypersensitivity reactions and infusion-site reactions in certain settings. In oncology, for instance, some polysorbate 80-containing formulations have been associated with a higher risk of systemic reactions, with the risk varying by factors like whether the drug is given through a peripheral line versus a central one and how many prior doses the patient has received.10PubMed Central. Safety of Polysorbate 80 in the Oncology Setting
High-dose intravenous vitamin C, which some patients seek outside of conventional oncology, presents its own issue. The solution is highly concentrated, and that hyperosmolar load can trigger thirst, shakiness, and general discomfort during and after the infusion. These symptoms are driven by the osmotic stress of infusing a very concentrated solution and can often be reduced by adjusting the dose or slowing the drip rate.11PLOS ONE. High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial
The Role of Anxiety and Sitting Still
Not every cause of post-infusion fatigue is pharmacological. The experience of receiving an infusion is physically passive but psychologically taxing for many people. You sit in a chair for one to several hours, often in a clinical setting surrounded by other patients on treatment. The anticipation of potential side effects, the discomfort of a needle, and the boredom of waiting all contribute to a kind of mental exhaustion that registers as physical tiredness by the time you leave.
Needle-related fear amplifies this effect. A large international survey found that anxiety and pain surrounding medical procedures were reported as contributors to needle fear by over 95% of people who identified as having that fear, and the average intensity of that fear was rated around 6 out of 10.12PubMed Central. Prevalence, causes, impacts, and management of needle phobia: An international survey of a general adult population For patients who need regular infusions, this procedural stress compounds over time. The fatigue a person attributes to the drug may partly reflect hours of sustained low-grade anxiety and physical tension. Acknowledging this as a real contributor, rather than dismissing it as “all in your head,” is the first step toward managing it.
When the Fatigue Is the Disease, Not the Infusion
One of the hardest questions to untangle is whether post-infusion tiredness is caused by the treatment or by the condition being treated. Many people who need infusions are already living with diseases that cause profound fatigue on their own: autoimmune conditions, cancer, chronic infections, and severe anemia all independently produce exhaustion. The infusion may add its own layer of fatigue on top, but separating the treatment’s contribution from the disease’s contribution is genuinely difficult.
The IVIG wear-off data illustrates this clearly. The fact that fatigue in immunodeficiency patients worsened as immunoglobulin levels declined, and that those fatigued patients had more infections during the wear-off period, suggests that their tiredness was at least partly driven by the return of their underlying immune deficiency rather than a lingering drug effect.8Clinical and Experimental Immunology. Fatigue and the wear-off effect in adult patients with common variable immunodeficiency
Blood transfusions offer a useful contrast. In patients hospitalized with anemia, receiving transfused red blood cells was associated with reduced fatigue one week after discharge, and the benefit scaled with the number of units received: patients who got two to three units saw roughly triple the fatigue reduction of those who received just one.13PubMed Central. The effect of red blood cell transfusion on fatigability after hospital discharge Here the infusion is directly correcting the cause of fatigue rather than adding to it. The lesson is that an infusion’s net effect on your energy depends entirely on what is being infused and what problem it is addressing.
Slowing the Drip and Other Practical Adjustments
When fatigue is driven by the infusion process itself rather than the underlying disease, several strategies can help. The most straightforward is adjusting the infusion rate. Slowing the drip gives your body more time to process what is entering the bloodstream and can reduce the intensity of cytokine-driven reactions. For immunoglobulin infusions, immediate side effects can be managed by slowing or briefly pausing the infusion, sometimes combined with analgesics or anti-inflammatory drugs for more severe reactions.14PubMed. Intravenous immunoglobulin: adverse effects and safe administration For certain antifungal drugs, extending the infusion from the standard two hours to five or six hours has been explored as a way to reduce infusion-related reactions, though the evidence here comes from limited data rather than large controlled trials.15PubMed. The Effect of Preoperative Oral Carbohydrate Solution Intake on Patient Comfort: A Randomized Controlled Study
Hydration before and during infusions matters more than most patients realize. Arriving at your infusion appointment already well-hydrated can make a measurable difference in how you feel afterward. Research on preoperative carbohydrate-rich drinks has shown that having something in your system before a medical procedure reduces discomfort markers including fatigue and headache.15PubMed. The Effect of Preoperative Oral Carbohydrate Solution Intake on Patient Comfort: A Randomized Controlled Study While this study looked at surgical patients rather than infusion patients specifically, the physiology is analogous: dehydration and fasting amplify the body’s stress response and leave you starting the procedure from a deficit.
Switching pre-medications is another lever. As noted earlier, replacing diphenhydramine with a non-sedating antihistamine can eliminate a major source of drowsiness without sacrificing protection against infusion reactions. This is a conversation to have with your infusion nurse or prescribing physician, since institutional protocols vary and there may be specific reasons a sedating antihistamine was chosen for your regimen.
What Structured Self-Management Programs Have Shown
Given how common infusion-related fatigue is, researchers have tested whether structured programs that teach energy conservation, sleep hygiene, and activity pacing can reduce it. The results have been humbling. A randomized trial testing a self-management intervention called EASE in cancer patients undergoing chemotherapy found no significant difference in fatigue, sleep quality, or functional status between the intervention group and the control group.16PubMed Central. Efficacy of an Intervention for Fatigue and Sleep Disturbance During Cancer Chemotherapy That does not mean self-care is useless, but it does suggest that when fatigue is driven by cytokine release, immune activation, or drug side effects, behavioral strategies alone are not enough to override the biology. The most effective management targets the physiological causes directly: adjusting medications, changing infusion rates, and addressing treatable contributors like dehydration or phosphate depletion.
Saline Infusions and Dysautonomia
An interesting case on the other side of the spectrum involves patients with dysautonomia, a group of conditions in which the autonomic nervous system does not regulate blood pressure and heart rate properly. These patients often experience chronic fatigue and have been treated with intravenous saline infusions to boost their blood volume. A case series in patients with myalgic encephalomyelitis/chronic fatigue syndrome found that intermittent saline infusions averaging about 1,600 milliliters per session lowered heart rate by an average of 11 beats per minute and reduced composite symptom scores by roughly 28% over the course of treatment.17PubMed Central. Beneficial effects of intermittent intravenous saline infusion in dysautonomic patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a case-series In this context, the infusion is not causing fatigue but treating it, by correcting a volume deficit that contributes to the patient’s symptoms. It is a useful reminder that the relationship between infusions and tiredness runs in both directions, depending entirely on what problem the infusion is solving and what side effects it introduces along the way.